Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Extracellular vesicles in ovarian cancer chemoresistance, metastasis, and immune evasion
Wanjia Tian, Ningjing Lei, Junying Zhou, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 89

Showing 1-25 of 89 citing articles:

Wnt signaling pathway: A comprehensive review
Rabia Hayat, Maleeha Manzoor, Ali Hussain
Cell Biology International (2022) Vol. 46, Iss. 6, pp. 863-877
Closed Access | Times Cited: 170
Exosomal circular RNAs: A chief culprit in cancer chemotherapy resistance
Xu Guo, Congying Gao, Dong‐Hua Yang, et al.
Drug Resistance Updates (2023) Vol. 67, pp. 100937-100937
Closed Access | Times Cited: 87
Tumor-associated macrophage-specific CD155 contributes to M2-phenotype transition, immunosuppression, and tumor progression in colorectal cancer
Xudong Zhu, Rongpu Liang, Tianyun Lan, et al.
Journal for ImmunoTherapy of Cancer (2022) Vol. 10, Iss. 9, pp. e004219-e004219
Open Access | Times Cited: 53
Biological functions and molecular interactions of Wnt/β-catenin in breast cancer: Revisiting signaling networks
Mehrdad Hashemi, Sahar Hasani, Shima Hajimazdarany, et al.
International Journal of Biological Macromolecules (2023) Vol. 232, pp. 123377-123377
Closed Access | Times Cited: 23
Cancer chemoresistance and its mechanisms: Associated molecular factors and its regulatory role
Sandra Kannampuzha, Abilash Valsala Gopalakrishnan
Medical Oncology (2023) Vol. 40, Iss. 9
Closed Access | Times Cited: 22
Harnessing GMNP-loaded BMSC-derived EVs to target miR-3064-5p via MEG3 overexpression: Implications for diabetic osteoporosis therapy in rats
Chen Xu, Zhaodong Wang, Ya Jun Liu, et al.
Cellular Signalling (2024) Vol. 118, pp. 111055-111055
Closed Access | Times Cited: 6
Supervillin‐Mediated ZO‐1 Downregulation Facilitates Migration of Cisplatin‐Resistant HCT116 Colorectal Cancer Cells
Yali Hong, Li Xu, Rongchen Mao, et al.
Journal of Cellular Biochemistry (2025) Vol. 126, Iss. 1
Open Access
Exploring Strategies to Prevent and Treat Ovarian Cancer in Terms of Oxidative Stress and Antioxidants
Yanru Long, Houhui Shi, Jiatian Ye, et al.
Antioxidants (2025) Vol. 14, Iss. 1, pp. 114-114
Open Access
Extracellular Vesicle–Packaged circATP2B4 Mediates M2 Macrophage Polarization via miR-532-3p/SREBF1 Axis to Promote Epithelial Ovarian Cancer Metastasis
Fang Wang, Yuequn Niu, Kelie Chen, et al.
Cancer Immunology Research (2022) Vol. 11, Iss. 2, pp. 199-216
Open Access | Times Cited: 28
Inaugurating High‐Throughput Profiling of Extracellular Vesicles for Earlier Ovarian Cancer Detection
Ala Jo, Allen Green, Jamie E. Medina, et al.
Advanced Science (2023) Vol. 10, Iss. 27
Open Access | Times Cited: 19
Exploiting Albumin as a Versatile Carrier for Cancer Theranostics
Yucen Tao, Vivianne Jakobsson, Xiaoyuan Chen, et al.
Accounts of Chemical Research (2023) Vol. 56, Iss. 18, pp. 2403-2415
Closed Access | Times Cited: 15
Therapeutic potential of extracellular vesicles from diverse sources in cancer treatment
Haihong Lin, Jun Zhou, Tao Ding, et al.
European journal of medical research (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 5
Performance evaluation of optimized convolutional neural network mechanism in the detection and classification of ovarian cancer
Kongara Srinivasa Rao, S Prakasha, A. Brindha, et al.
Multimedia Tools and Applications (2024) Vol. 83, Iss. 28, pp. 71311-71334
Closed Access | Times Cited: 4
Exosomes in diagnostic and therapeutic applications of ovarian cancer
Dhaval Bhavsar, Rajeswari Raguraman, Dongin Kim, et al.
Journal of Ovarian Research (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 4
Tumor microenvironment manipulates chemoresistance in ovarian cancer (Review)
Qiaoling Zhang, Jiashan Ding, Yingmei Wang, et al.
Oncology Reports (2022) Vol. 47, Iss. 5
Open Access | Times Cited: 22
Extracellular Vesicles-ceRNAs as Ovarian Cancer Biomarkers: Looking into circRNA-miRNA-mRNA Code
Giuseppe Cammarata, Nadia Barraco, Ilaria Giusti, et al.
Cancers (2022) Vol. 14, Iss. 14, pp. 3404-3404
Open Access | Times Cited: 21
Advanced Nanosystems for Cancer Therapeutics: A Review
Fatemeh Mohajer, Boshra Mirhosseini‐Eshkevari, Sepideh Ahmadi, et al.
ACS Applied Nano Materials (2023) Vol. 6, Iss. 9, pp. 7123-7149
Closed Access | Times Cited: 13
A novel defined risk signature of endoplasmic reticulum stress-related genes for predicting the prognosis and immune infiltration status of ovarian cancer
Jiahang Mo, Shunyi Ruan, Baicai Yang, et al.
Journal of Zhejiang University SCIENCE B (2023) Vol. 24, Iss. 1, pp. 64-77
Open Access | Times Cited: 12
Extracellular vesicles carrying miR-6836 derived from resistant tumor cells transfer cisplatin resistance of epithelial ovarian cancer via DLG2-YAP1 signaling pathway
Yazhu Zou, Zitong Zhao, Jingjing Wang, et al.
International Journal of Biological Sciences (2023) Vol. 19, Iss. 10, pp. 3099-3114
Open Access | Times Cited: 12
Graphene oxide nanoarchitectures in cancer therapy: Drug and gene delivery, phototherapy, immunotherapy, and vaccine development
Mohammad Saleh Sadeghi, Faezeh Hosseini Sangrizeh, Negar Jahani, et al.
Environmental Research (2023) Vol. 237, pp. 117027-117027
Closed Access | Times Cited: 12
Single-cell and transcriptomic analyses reveal the influence of diabetes on ovarian cancer
Zhihao Zhao, Qilin Wang, Fang Zhao, et al.
BMC Genomics (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 3
Involvement of Protease-Activated Receptor2 Pleckstrin Homology Binding Domain in Ovarian Cancer: Expression in Fallopian Tubes and Drug Design
Jeetendra Kumar Nag, Sorina Grisaru‐Granovsky, Shunit Armon, et al.
Biomedicines (2024) Vol. 12, Iss. 1, pp. 246-246
Open Access | Times Cited: 3
Artificial intelligence in ovarian cancer drug resistance advanced 3PM approach: subtype classification and prognostic modeling
Cong Zhang, Jinxiang Yang, Siyu Chen, et al.
The EPMA Journal (2024) Vol. 15, Iss. 3, pp. 525-544
Closed Access | Times Cited: 3
Proteomic Profiling of Fallopian Tube-Derived Extracellular Vesicles Using a Microfluidic Tissue-on-Chip System
Didi Zha, Sagar Rayamajhi, Jared Sipes, et al.
Bioengineering (2023) Vol. 10, Iss. 4, pp. 423-423
Open Access | Times Cited: 10
Methods to Evaluate Changes in Mitochondrial Structure and Function in Cancer
Brittany P. Rickard, Marta Overchuk, Vesna A. Chappell, et al.
Cancers (2023) Vol. 15, Iss. 9, pp. 2564-2564
Open Access | Times Cited: 10
Page 1 - Next Page

Scroll to top